Pasireotide for the treatment of refractory hypoglycaemia from malignant insulinoma

E-ISSN： 1365-2265|88|2|341-343

ISSN： 0300-0664

Source： CLINICAL ENDOCRINOLOGY, Vol.88, Iss.2, 2018-02, pp. : 341-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Colchicine: An Effective Treatment for Refractory Malignant Pericardial Effusion

Acta Haematologica, Vol. 104, Iss. 4, 2001-03 ,pp. : 217-219

Karger

Access to resources Recommend Favorite

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

CLINICAL ENDOCRINOLOGY, Vol. 81, Iss. 3, 2014-09 ,pp. : 408-417

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gemcitabine and Cisplatin in Refractory Malignant Lymphoma

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 197-200

Karger

Access to resources Recommend Favorite

Treatment delay in cutaneous malignant melanoma: from first contact to definitive treatment

By Murchie Peter

Quality in Primary Care, Vol. 15, Iss. 6, 2007-12 ,pp. : 345-351

Radcliffe Press

Access to resources Recommend Favorite

Hypoglycaemia

DIABETIC MEDICINE, Vol. 16, Iss. S1, 1999-05 ,pp. : 72-72

John Wiley & Sons Inc

Access to resources Recommend Favorite